Table 2.
Evidence Domain | Differences in Objections between Successful ATMPs and Biologicals Submissions (n = 24) |
Differences in Objections between Failed ATMPs and Biologicals Submissions (n = 10) |
||
---|---|---|---|---|
Z | p (Two-Tailed) | Z | p (Two-Tailed) | |
Manufacturing and quality | −1.380 | 0.186 | −0.674 | 0.625 |
Experimental design and conduct of the studies | −2.221 | 0.021∗ | −0.674 | 0.625 |
Efficacy and MoA | −2.108 | 0.031∗ | −0.137 | 1 |
Safety and toxicity | −0.431 | 0.727 | −0.552 | 0.750 |
Total number of objections | −2.396 | 0.013∗ | −0.674 | 0.625 |
∗p < 0.05. p values were determined by a Wilcoxon signed-rank test.